The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

After a thorough examination, Hanaa was diagnosed with gyrate atrophy, a rare genetic condition, along with advanced ...

The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Yemeni woman travels to UAE for life-changing treatment, reinforcing Abu Dhabi’s status as a global healthcare hub ...

Clearside Biomedical, Inc. announced upcoming presentations featuring data from its CLS-AX sub-group analyses from the Phase 2b ODYSSEY trial for the treatment of wet age-related macular ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

[45] *Included patients with macular edema due to various etiologies, including diabetes. NA = Not available. Stephen G. Schwartz, Bascom Palmer Eye Institute, University of Miami Miller School of ...

Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...

Second, the higher level of inflammation secondary to the more traumatic surgery means that the risk of cystoid macular edema (CME) rises from 1.4% for uncomplicated cataract surgeries to 7.3% in ...

wet age-related macular degeneration (wAMD), cystoid retinal vein occlusive (CRVO-BRVO) macular edema, choroidal neovascularization and diabetic macular edema. It is administered through intravitreal ...